59.50
+0.50
+(0.85%)
At close: January 22 at 2:59:43 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
20,633.00
20,633.00
13,643.00
11,075.00
13,261.00
Cost of Revenue
15,359.00
15,359.00
10,927.00
9,272.00
8,290.00
Gross Profit
5,274.00
5,274.00
2,716.00
1,803.00
4,971.00
Operating Expense
68,127.00
68,127.00
69,003.00
64,012.00
55,299.00
Operating Income
-62,853.00
-62,853.00
-66,287.00
-62,209.00
-50,328.00
Net Non Operating Interest Income Expense
2,068.00
2,068.00
1,423.00
1,087.00
1,609.00
Pretax Income
-58,915.00
-58,915.00
-83,134.00
-60,967.00
-48,478.00
Tax Provision
-964.00
-964.00
-16,048.00
-1,262.00
-560.00
Net Income Common Stockholders
-57,951.00
-57,951.00
-67,086.00
-59,705.00
-47,918.00
Diluted NI Available to Com Stockholders
-57,951.00
-57,951.00
-67,086.00
-59,705.00
-47,918.00
Basic EPS
-1.03
--
-1.22
-1.11
-0.89
Diluted EPS
-1.03
--
-1.22
-1.11
-0.89
Basic Average Shares
56,151.00
--
54,880.00
53,970.00
53,556.00
Diluted Average Shares
56,151.00
--
54,880.00
53,970.00
53,556.00
Total Expenses
83,486.00
83,486.00
79,930.00
73,284.00
63,589.00
Net Income from Continuing & Discontinued Operation
-57,951.00
-57,951.00
-67,086.00
-59,705.00
-47,918.00
Normalized Income
-57,951.00
-57,951.00
-67,086.00
-59,705.00
-47,918.00
Interest Income
2,244.00
2,244.00
1,678.00
1,348.00
1,710.00
Interest Expense
176.00
176.00
255.00
261.00
101.00
Net Interest Income
2,068.00
2,068.00
1,423.00
1,087.00
1,609.00
EBIT
-58,739.00
-58,739.00
-82,879.00
-60,706.00
-48,377.00
EBITDA
-35,846.00
-35,846.00
-57,015.00
-35,819.00
-24,035.00
Reconciled Cost of Revenue
15,359.00
15,359.00
10,927.00
9,272.00
8,290.00
Reconciled Depreciation
22,893.00
22,893.00
25,864.00
24,887.00
24,342.00
Net Income from Continuing Operation Net Minority Interest
-57,951.00
-57,951.00
-67,086.00
-59,705.00
-47,918.00
Normalized EBITDA
-35,846.00
-35,846.00
-57,015.00
-35,819.00
-24,035.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
12/31/2020 - 12/25/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6986.TWO HeXun Biosciences Co., Ltd.
70.00
-0.57%
6610.TWO TWi Biotechnology, Inc.
13.70
+0.74%
7814.TWO HORIEN
29.95
-4.92%
7773.TWO FullHope
41.60
-0.60%
7808.TWO BIONET TX Corp
46.00
-0.33%
4178.TWO StemCyte International, Ltd.
34.20
-0.44%
4169.TWO TCM Biotech International Corp.
57.20
+1.78%
6704.TWO Gwo Xi Stem Cell Applied Technology Co. , Ltd
27.60
+0.36%
7607.TWO DuoGenic StemCells corporation
18.10
-3.98%
6634.TWO Sinew Pharma Inc.
49.55
+1.12%